Dae-Woong Cho
Vorstandsvorsitzender bei CELLIVERY THERAPEUTICS, INC.
Vermögen: 26 Mio $ am 31.03.2023
Aktive Positionen von Dae-Woong Cho
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELLIVERY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.08.2014 | - |
| Vorstandsvorsitzender | 28.08.2014 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 28.08.2014 | - | |
| Gründer | 14.03.2014 | - |
Karriereverlauf von Dae-Woong Cho
Ehemalige bekannte Positionen von Dae-Woong Cho
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Gründer | 20.12.2005 | - |
| Präsident | 09.04.2010 | - | |
| Chonnam National University | Corporate Officer/Principal | - | - |
| YUHAN CORPORATION | Corporate Officer/Principal | - | - |
GenoCheck Co., Ltd.
 GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | - | - |
| Vanderbilt University | Corporate Officer/Principal | - | - |
Ausbildung von Dae-Woong Cho
| Vanderbilt University | Doctorate Degree |
| Hanyang University | Graduate Degree |
Statistik
International
| Südkorea | 7 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Founder | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CELLIVERY THERAPEUTICS, INC. | Health Technology |
| YUHAN CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Health Technology |
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Börse
- Insiders
- Dae-Woong Cho
- Erfahrung
